LLY
Eli Lilly and Company
1,151.00$
-1.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.31 | -0.35 | 1.29 | 1.62 | 4.10 | 2.74 | 1.85 | 3.43 | 9.83 | 3.59 | 5.95 | 11.96 | 31.42 | |
| 0.43 | 0.43 | 0.44 | 0.46 | 0.52 | 0.54 | 0.51 | 0.53 | 0.52 | 0.65 | 0.57 | 0.60 | 2.35 | |
| 0.23 | 0.13 | 0.18 | 0.23 | 0.15 | 0.16 | 0.17 | 0.21 | 0.17 | 0.15 | 0.18 | 0.22 | 0.73 | |
| 1.10 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.84 | -3.51 | -1.94 | -1.55 | -0.01 | -2.46 | -3.74 | -2.51 | 1.34 | -4.09 | -1.86 | -0.75 | -5.37 | |
| 4.21 | 1.83 | 1.09 | 1.55 | 4.61 | 1.93 | 3.63 | 2.00 | 0.25 | 2.84 | 2.60 | 3.28 | 8.98 | |
| -3.25 | -3.23 | -1.30 | -2.43 | -4.43 | -2.13 | -3.72 | -2.04 | -3.32 | -3.12 | -4.37 | -17.23 | -28.08 | |
| 1.07 | 1.13 | 1.29 | 1.30 | 1.29 | 1.29 | 1.49 | 1.50 | 1.50 | 1.50 | 1.73 | 1.73 | 6.47 | |
| -0.79 | 0.83 | 0.00 | 0.00 | -0.49 | -2.27 | -1.33 | -0.77 | -0.79 | -1.68 | -2.63 | -1.79 | -6.91 | |
| 1.68 | – | – | – | 2.07 | 3.37 | 5.12 | 0.92 | 2.91 | 0.00 | 1.14 | 12.95 | 17.03 | |
| 0.60 | 3.92 | -0.34 | 1.72 | 0.23 | -0.25 | 1.53 | -1.38 | 0.59 | -3.21 | -3.87 | 9.43 | 2.92 | |
| -0.33 | 0.48 | -0.40 | 0.84 | 0.16 | -0.11 | -0.19 | 0.31 | 7.14 | -2.81 | -2.22 | 4.10 | 6.24 | |
| -1.91 | -2.17 | 0.20 | 0.07 | -0.51 | 0.80 | -1.78 | 1.43 | 9.58 | 0.75 | 3.36 | 8.68 | 22.44 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.